Works matching AU LaBarbera, Daniel V.

Results: 15

CHD1L in cancer and beyond: structure, oncogenic functions, and therapeutic potential.

Published in:

Journal of Experimental & Clinical Cancer Research (17569966), 2025, v. 44, n. 1, p. 1, doi. 10.1186/s13046-025-03428-1

By:

Clune, Sophia;
Awolade, Paul;
Esquer, Hector;
Zhou, Qiong;
LaBarbera, Daniel V.

Publication type:

Article

Targeting HIV-1 Protease Autoprocessing for High-throughput Drug Discovery and Drug Resistance Assessment.

Published in:

Scientific Reports, 2019, v. 9, n. 1, p. 1, doi. 10.1038/s41598-018-36730-4

By:

Huang, Liangqun;
Li, Linfeng;
Tien, ChihFeng;
LaBarbera, Daniel V.;
Chen, Chaoping

Publication type:

Article

Larrea tridentata: A novel source for anti-parasitic agents active against Entamoeba histolytica, Giardia lamblia and Naegleria fowleri.

Published in:

PLoS Neglected Tropical Diseases, 2017, v. 11, n. 8, p. 1, doi. 10.1371/journal.pntd.0005832

By:

Bashyal, Bharat;
Li, Linfeng;
Bains, Trpta;
Debnath, Anjan;
LaBarbera, Daniel V.

Publication type:

Article

The Isolation and Characterization of β-Glucogallin as a Novel Aldose Reductase Inhibitor from Emblica officinalis.

Published in:

PLoS ONE, 2012, v. 7, n. 4, p. 1, doi. 10.1371/journal.pone.0031399

By:

Puppala, Muthenna;
Ponder, Jessica;
Suryanarayana, Palla;
Reddy, Geereddy Bhanuprakash;
Petrash, J. Mark;
LaBarbera, Daniel V.

Publication type:

Article

Response of Osteosarcoma Cell Lines to a Novel CHD1L Inhibitor.

Published in:

FASEB Journal, 2022, v. 36, p. N.PAG, doi. 10.1096/fasebj.2022.36.S1.R4881

By:

Gustafson, Daniel L.;
Viola, Lindsey;
LaBarbera, Daniel V.

Publication type:

Article

SBI<sup>2</sup> HCS/HCA 3D Imaging: Best Practices and Unmet Needs Colloquium.

Published in:

Assay & Drug Development Technologies, 2017, v. 15, n. 1, p. 1, doi. 10.1089/adt.2016.29054.afh

By:

Hoffman, Ann F.;
Simpson, Kaylene J.;
Horvath, Peter;
Lovitt, Carrie;
Silver, Serena;
Easton, Evan;
LaBarbera, Daniel V.;
Mendez, Melissa;
Rothenberg, Mark E.;
Seldin, Jan;
Wardwell-Swanson, Judi;
Fennell, Myles

Publication type:

Article

Inhibition of α-glucosidase, α-amylase, and aldose reductase by potato polyphenolic compounds.

Published in:

PLoS ONE, 2018, v. 13, n. 1, p. 1, doi. 10.1371/journal.pone.0191025

By:

Kalita, Diganta;
Holm, David G.;
LaBarbera, Daniel V.;
Petrash, J. Mark;
Jayanty, Sastry S.

Publication type:

Article

An Improved High Yield Total Synthesis and Cytotoxicity Study of the Marine Alkaloid Neoamphimedine: An ATP-Competitive Inhibitor of Topoisomerase IIα and Potent Anticancer Agent.

Published in:

Marine Drugs, 2014, v. 12, n. 9, p. 4833, doi. 10.3390/md12094833

By:

Li, Linfeng;
Abraham, Adedoyin D.;
Qiong Zhou;
Ali, Hadi;
O'Brien, Jeremy V.;
Hamill, Brayden D.;
Arcaroli, John J.;
Messersmith, Wells A.;
LaBarbera, Daniel V.

Publication type:

Article

Neoamphimedine Circumvents Metnase-Enhanced DNA Topoisomerase IIα Activity Through ATP-Competitive Inhibition.

Published in:

Marine Drugs, 2011, v. 9, n. 11, p. 2397, doi. 10.3390/md9112397

By:

Ponder, Jessica;
Byong Hoon Yoo;
Abraham, Adedoyin D.;
Qun Li;
Ashley, Amanda K.;
Amerin, Courtney L.;
Qiong Zhou;
Reid, Brian G.;
Reigan, Philip;
Hromas, Robert;
Nickoloff, Jac A.;
LaBarbera, Daniel V.

Publication type:

Article

New Destruxins from the Marine-derived Fungus Beauveria felina.

Published in:

Journal of Antibiotics, 2006, v. 59, n. 9, p. 553, doi. 10.1038/ja.2006.76

By:

Lira, Simone P;
Vita-marques, Aline M;
Seleghim, Mirna H R;
Bugni, Tim S;
Labarbera, Daniel V;
Sette, Lara D;
Sponchiado, Sandra R P;
Ireland, Chris M;
Berlinck, Roberto G S

Publication type:

Article

Targeted Inhibition of CHD1L by OTI-611 Reprograms Chemotherapy and Targeted Therapy-Induced Cell Cycle Arrest and Suppresses Proliferation to Produce Synergistic Antitumor Effects in Breast and Colorectal Cancer.

Published in:

Cells (2073-4409), 2025, v. 14, n. 5, p. 318, doi. 10.3390/cells14050318

By:

Esquer, Hector;
Zhou, Qiong;
LaBarbera, Daniel V.

Publication type:

Article

CHD1L Inhibitor OTI-611 Synergizes with Chemotherapy to Enhance Antitumor Efficacy and Prolong Survival in Colorectal Cancer Mouse Models.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 23, p. 13160, doi. 10.3390/ijms252313160

By:

Sala, Rita;
Esquer, Hector;
Kellett, Timothy;
Clune, Sophia;
Awolade, Paul;
Pike, Laura A.;
Zhou, Qiong;
Messersmith, Wells A.;
LaBarbera, Daniel V.

Publication type:

Article

CHD1L Regulates Cell Survival in Breast Cancer and Its Inhibition by OTI-611 Impedes the DNA Damage Response and Induces PARthanatos.

Published in:

International Journal of Molecular Sciences, 2024, v. 25, n. 16, p. 8590, doi. 10.3390/ijms25168590

By:

Sala, Rita;
Esquer, Hector;
Kellett, Timothy;
Kearns, Jeffrey T.;
Awolade, Paul;
Zhou, Qiong;
LaBarbera, Daniel V.

Publication type:

Article

AST-487 Inhibits RET Kinase Driven TERT Expression in Bladder Cancer.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810819

By:

Agarwal, Neeraj;
Zhou, Qiong;
Arya, Deepak;
Rinaldetti, Sébastien;
Duex, Jason;
LaBarbera, Daniel V.;
Theodorescu, Dan

Publication type:

Article

High-Content Drug Discovery Targeting Molecular Bladder Cancer Subtypes.

Published in:

International Journal of Molecular Sciences, 2022, v. 23, n. 18, p. N.PAG, doi. 10.3390/ijms231810605

By:

Rinaldetti, Sébastien;
Zhou, Qiong;
Abbott, Joshua M.;
de Jong, Florus C.;
Esquer, Hector;
Costello, James C.;
Theodorescu, Dan;
LaBarbera, Daniel V.

Publication type:

Article